涩里番

涩里番 researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

In a study published in , the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

涩里番 researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

In a study published in , the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

涩里番 researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

In a study published in , the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

涩里番 researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

In a study published in , the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

涩里番 researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

In a study published in , the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

涩里番 researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

In a study published in , the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

涩里番 researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

In a study published in , the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

涩里番 researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

In a study published in , the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

96 Global Health NOW: U.S. Government Shutdown Centers on Health Care; Bangladesh Bets on British Malaria Vaccine; and Inside China鈥檚 Detention Camps Plus: President Trump's deal with Pfizer to lower Medicaid drug prices October 1, 2025 The U.S. Capitol at dawn on October 1, in Washington, D.C. Al Drago/Getty Images Health Care Hangs in the Balance as U.S. Government Shuts Down    Funding for the U.S. government has halted amid a Congressional deadlock over federal health spending鈥攆urther imperiling health agencies in an already tumultuous period, .    Subsidies at the center: The impasse centers on Affordable Care Act subsidies, set to expire after 2025. Democrats want an extension, as well as a restoration of Medicaid cuts enacted over the summer; Republicans demand reforms first. 

• Without renewed subsidies, insurers warn of double-digit premium increases.  

Health services at risk: If a shutdown drags on, impacts to health operations include:  

• ~40% of HHS workers furloughed 

• NIH clinical trials put on hold 

• FDA food safety efforts curtailed  

• Disease surveillance and local CDC support disrupted 

• Community health centers at risk of closure 

Drug price deal: Meanwhile, yesterday President Trump announced a deal with Pfizer to lower Medicaid drug prices and sell discounted drugs via a direct-to-consumer site dubbed TrumpRx.gov, 鈥攑art of an effort to align drug prices in the U.S. with those in other countries.  

• U.S. patients often pay nearly 3X more for prescription drugs than patients in other developed nations, where governments set rates, .  

• Prices on the TrumpRx site, launching in 2026, follow a 鈥渕ost-favored-nation鈥� model, matching the lowest rates in other developed countries. The deal targets uninsured consumers, and experts say most Americans will see limited savings overall. 

More U.S. Health Policy News:     Trump orders $50M for AI in pediatric cancer research 鈥�     Medicaid work requirements have not boosted insurance coverage or employment, study finds 鈥�   GLOBAL HEALTH VOICES The Latest One-Liners
A surge of visceral leishmaniasis, also known as Kala-azar, has led a Kenyan county to declare a public health emergency; 850 infections of the deadly parasitic disease were recorded between June 2024 and August 2025.     Rohingya urgently need an influx of international support, says the UN鈥檚 refugee chief, as in Myanmar they continue to 鈥渓ive with the threat of arbitrary arrest and detention, with restricted access to health care and education鈥�; at the same time, the humanitarian response to the 1.2 million Rohingya refugees in Bangladesh 鈥渞emains chronically underfunded.鈥�     Mpox response across Africa is being analyzed at a gathering of countries鈥� health officials and Africa CDC officials in Addis Ababa this week, ; meanwhile, vaccine experts are warning that waning immunity to smallpox ~50 years after the last vaccination campaign is leading to increased vulnerability to mpox, .    The rise of early-onset cancers in U.S. adults could be due to increased detection and overdiagnosis rather than a true spike in the disease, , which looked at the eight cancers with the fastest-rising incidence among adults under 50.   MALARIA Bangladesh Bets on British Vaccine    Over the last decade, Bangladesh has made huge strides against malaria: Cases in the south Asian nation dropped from ~57,000 in 2014 to 13,000 in 2024. 

• But the disease has a final stronghold: The Chittagong Hill Tracts, a region bordering India and Myanmar, where ~90% of Bangladesh鈥檚 remaining malaria cases are found.   

In an attempt to eliminate the disease, researchers are traveling across the remote region to immunize thousands of villagers, in the first mass rollout in Asia of the British malaria vaccine R21.  

• Researchers say the approach could speed up elimination efforts in hard-to-reach areas exponentially, allowing more countries to follow the likes of China, Sri Lanka, and Belize in wiping out the illness. 

  GLOBAL HEALTH VOICES HUMAN RIGHTS Inside China鈥檚 Detention Camps    A former schoolteacher coerced into working in mass detention camps in Xinjiang, China, has publicly spoken about the conditions inside, which included torture, forced labor, and forced sterilization.  

• Over 1 million Muslims from ethnic groups such as the Uyghurs have been detained in these high-security camps, which the Chinese government claims are vocational centers鈥攂ut rights groups allege involve genocide. 

Eyewitness testimony: Qalbinur Sidiq, who is ethnically Uzbek, was a Chinese elementary school teacher before she was forced to work as a Chinese teacher in two camps. Sidiq, 55, was eventually sterilized against her will and reports seeing young women forcibly sterilized.     Sidiq received asylum in the Netherlands in 2019. Now, she speaks out against China鈥檚 policies toward Uyghurs and Muslim minorities.       QUICK HITS 鈥榃ill my baby be born in a tent? Will it have food?鈥�: what it鈥檚 like to be pregnant in Gaza 鈥�     Listeria found in Walmart, Trader Joe鈥檚 meals may be linked to deadly outbreak 鈥�     Kentucky has kicked people off food benefits using data that doesn鈥檛 tell the full story 鈥�     AI-generated 鈥榩articipants鈥� can lead social science experiments astray, study finds 鈥�      Should the Autism Spectrum Be Split Apart? 鈥�  

Manifesting isn't all "woo-woo." Science says you can train your brain 鈥� Issue No. 2797
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.

Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on and follow us on Instagram and X .

Please send the Global Health NOW free sign-up link to friends and colleagues:

Want to change how you receive these emails? You can or . -->



  Copyright 2025 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.


Want to change how you receive these emails?
You can or .

Immunisation experts at the UN World Health Organization (WHO) have warned that global protection against preventable diseases is under threat, in part because of an 鈥渋nformation and trust crisis鈥� regarding vaccines.

J茅r么me Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.聽聽

The 涩里番 researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.聽

J茅r么me Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.聽聽

The 涩里番 researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.聽

J茅r么me Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.聽聽

The 涩里番 researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.聽

J茅r么me Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.聽聽

The 涩里番 researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.聽

J茅r么me Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.聽聽

The 涩里番 researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.聽

J茅r么me Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.聽聽

The 涩里番 researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.聽

J茅r么me Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.聽聽

The 涩里番 researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.聽

J茅r么me Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.聽聽

The 涩里番 researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.聽

J茅r么me Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.聽聽

The 涩里番 researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.聽

J茅r么me Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.聽聽

The 涩里番 researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.聽